UK development finance institution CDC Group has anchored a $130 million first close for a fund managed by a South Asian spin-out of US-based Global Environmental Fund Capital Advisors.
LeapFrog Investments has raised $700 million for its third fund with a view to investing in healthcare and financial services companies in emerging Asia and Africa. It initially targeted a corpus of $600 million.
Lighthouse Funds has closed its third India-focused middle-market growth capital vehicle at $230 million.
Global growth equity investor TA Associates has reached a first and final close on its latest fund – TA XIII – at the hard cap of $8.5 billion.
Just over two years after its founders spun out from KKR, DCP Capital has raised China’s joint-largest first-time fund on record. The firm sees opportunities emerging in a changing commercial environment
DCP Capital – a PE firm established by David Liu (pictured) and Julian Wolhardt, who previously held leadership positions with KKR in China – has closed its debut fund with around $2.5 billion in commitments. It comprises a US dollar-denominated tranche...
Source Code Capital, a Chinese VC firm founded by Yi Cao (pictured), formerly a partner at Sequoia Capital China, has closed two new US dollar vehicles at $570 million.
DSG Partners Asia, which targets early-stage consumer opportunities in India and Southeast Asia, has reached a first close of $30 million on its third fund.
The Carlyle Group has agreed to invest an undisclosed amount in Japanese cosmetics manufacturer Tokiwa to support its domestic and overseas expansion plans.
Singapore-based private equity firm Tembusu Partners has confirmed it will launch a series of funds to invest at least RMB1 billion ($149 million) in Chinese growth-stage companies.
China Investment Corporation (CIC) has teamed up with France-based GP Eurazeo and BNP Paribas to launch a Europe-China growth fund with a target corpus of EUR1-1.5 billion ($1.1-1.7 billion).
Chinese GPs that can identify where their strategies might go wrong – and therefore avoid problems before they emerge – are most likely to emerge as winners in a market characterized by rising competition and changing economic circumstances, LPs told...
Are concerns over trade and the economy causing US LPs to back away from Chinese private equity? The more pertinent question is whether - and how - they already have exposure to the market
TPG Capital has terminated Bill McGlashan (pictured), founder of its mid-market investment platform TPG Growth and co-founder of impact investment vehicle The Rise Fund, after he was charged this week for his role in the college bribery scandal in the...
Multiples Alternate Asset Management is seeking INR65.3 billion ($920 million) for its third India-focused private equity fund.
CDH Investments is seeking approximately $1 billion for its second China growth fund, just over two years after raising $800 million for the debut vehicle.
Philippines private equity firm Navegar has launched its second growth fund focused exclusively on its home market with a target of $150 million.
Quadrant Private Equity is planning to raise a A$300 million ($215 million) fund focused on growth equity investments in small and medium-sized enterprises in Australia.
Shenzhen Capital Group and SOSV Investments have agreed to establish a China-focused angel investment fund as well as a growth stage vehicle targeting European companies.
Lilly Asia Ventures (LAV) has closed its fifth healthcare fund – which operates globally but primarily backs companies with a China angle – at the hard cap of $750 million. It represents a meaningful step up in size from the $450 million raised for...
Having raised $250 million for its third India healthcare fund, Invascent Capital plans to take advantage of a greater willingness among entrepreneurs to work with financial investors
With the acquisition of IDFC Alternatives' private equity and real estate businesses, Investcorp secured a ready-made India investment platform
Ascendent Capital Partners is seeking $800 million for its third China mid-market fund. The GP closed its previous vehicle at $600 million in 2015.
Invascent Capital, an Indian healthcare-focused GP, has closed its third vehicle at the hard cap of $250 million.